The cannabinoid system and immune modulation. 28 May Dr D The case for peripheral CB₁ receptor blockade in the treatment of visceral obesity and its cardiometabolic complications. Anandamide suppresses proliferation and cytokine release from primary human T-lymphocytes mainly via CB2 receptors.